Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-17 Sale |
2021-08-17 7:39 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,407 | $17.12 | $24,085 | 47,614 (Direct) |
View |
| 2021-07-28 Sale |
2021-07-29 4:09 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,250 | $13.81 | $17,263 | 44,521 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:11 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
750 | $19.3 | $14,475 | 45,594 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:32 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
2,250 | $31.5 | $70,864 | 46,344 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:33 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,813 | $28.91 | $52,414 | 44,094 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:31 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,813 | $30.75 | $55,750 | 45,907 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-23 8:00 pm |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
750 | $18.48 | $13,860 | 27,555 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-22 9:20 pm |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
750 | $18.59 | $13,943 | 28,305 (Direct) |
View |
| 2020-07-28 Sale |
2020-07-30 7:48 pm |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
870 | $20.49 | $17,826 | 26,055 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-13 9:00 pm |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
527 | $16.98 | $8,951 | 26,728 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-24 Option Award |
2025-03-26 07:10 am |
N/A 2035-03-24 |
Verrica Pharmaceuticals Inc. | VRCA | Rosenberg Noah L. CMO |
325,000 | $0 | 325,000 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:39 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
4,500 | $0 | 47,614 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:49 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
4,500 | $0 | 48,594 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:31 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
5,000 | $0 | 45,907 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:57 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
72,500 | $0 | 100,220 (Direct) |
View |
| 2020-09-18 Option Award |
2020-09-22 9:20 pm |
N/A N/A |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
3,000 | $0 | 28,305 (Direct) |
View |